Schedule of Warrant activity (Details) - Warrant [Member] - $ / shares |
12 Months Ended | |
---|---|---|
Dec. 31, 2024 |
Dec. 31, 2023 |
|
Accumulated Other Comprehensive Income (Loss) [Line Items] | ||
Number of Warrants, Balance | 774,099 | 166,131 |
Weighted Average Exercise Price, Balance | $ 110.40 | $ 638.58 |
Number of Warrants, Issued | 10,413,376 | 1,052,951 |
Weighted Average Exercise Price, Issued | $ 1.71 | $ 8.07 |
Number of Warrants, Expired or rescinded | ||
Number of Warrants, Exercised | (1,424,384) | (444,983) |
Weighted Average Exercise Price, Exercised | $ 0.25 | $ 3.32 |
Number of Warrants, Balance | 9,763,091 | 774,099 |
Weighted Average Exercise Price, Balance | $ 8.75 | $ 110.40 |
X | ||||||||||
- Definition Share based Compensation Arrangement by Share Based Payment Award Equity Instruments Non optionss Outstanding weighted average Exercise Price. No definition available.
|
X | ||||||||||
- Definition Share based Compensation Arrangement by Share Based Payment Award Equity Instruments Non options exercised outstanding weighted average Exercise Price. No definition available.
|
X | ||||||||||
- Definition Share based Compensation Arrangement by Share Based Payment Award Equity Instruments Non options grants Outstanding weighted average Exercise Price. No definition available.
|
X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Number of non-option equity instruments exercised by participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Number of shares under non-option equity instrument agreements for which rights to exercise lapsed. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Net number of non-option equity instruments granted to participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Number of equity instruments other than options outstanding, including both vested and non-vested instruments. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Details
|